Veterinary Medicines

BASQUIN CL PLUS SUSPENSION INYECTABLE PARA BOVINO, OVINO, CAPRINO Y CONEJOS

Authorised
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B and D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
Download as PDF

Product identification

Medicine name:
BASQUIN CL PLUS SUSPENSION INYECTABLE PARA BOVINO, OVINO, CAPRINO Y CONEJOS
Active substance:
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B and D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
Target species:
  • Cattle
  • Sheep
  • Goat
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, Inactivated
    100.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B and D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI03AB
  • QI04AB01
  • QI08AB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ Vaccines S.A.U.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3187 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025
Download